Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

4.10
Delayed Data
As of Sep 30
 +0.17 / +4.33%
Today’s Change
1.63
Today|||52-Week Range
9.42
+102.97%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.93
Today’s open3.92
Day’s range3.85 - 4.15
Volume186,063
Average volume (3 months)95,295
Market cap$44.2M
Dividend yield--
Data as of 3:58pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+82.99%
Earnings growth (next 5 years)--
Revenue growth (last year)+315.65%
P/E ratioNM
Price/Sales1.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CNATConatus Pharmaceutic...-0.01-0.50%
AMPEAmpio Pharmaceutical...-0.02-2.61%
AXNAoxing Pharmaceutica...-0.00-0.34%
OREXOrexigen Therapeutic...+0.12+3.75%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$4.4M
Annual profit (last year)-$19.0M
Net profit margin-433.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts

Search for Jobs